- Country: USA
- Summary: NonSurgical Debridement
- UST Ref No: 122603112
- Deadline: 26 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75A50125R00007
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Treatment and care for burn injuries is both resource and labor intensive. The national capacity is typically limited and presents a significant limitation to when a sudden surge capacity is required in a burn mass casualty incident (BMCI). A BMCI in a geographic area could overwhelm a regional existing capacity and present to substantial resource constraints. To mitigate this challenge, BARDA has collaboratively worked with the burn care community to identify areas of improvement in the delivery of this care. This collaboration has identified numerous area which BARDA has systematically addressed over the years. The two major areas where enhanced treatment options could provide a meaningful difference are in the initial care and triage of patients, and secondly, in the long-term treatment and recovery steps of burn care. The focus of this RFP is to address the long-term treatment and recovery steps of burn care.
Surgical debridement is the current standard of care for removing dead skin tissue (eschar) from severe burn injuries, the required first step in definitive care. This involves shaving the burn area with bladed instruments and/or use of high-pressure water jets, both of which remove healthy tissue as well as the targeted necrotic tissue. These current debridement methods are labor-intensive, require highly specialized surgical training and resources, and invokes additional risk to the patient due to unavoidable removal of healthy skin. Furthermore, surgical debridement is usually delayed for the first few days after injury to allow for observation and visual assessment of its healing trajectory. This presents additional risks to the patient and potentially prolongs hospital stays. Enzymatic debridement products more selectively remove necrotic burned skin and can be applied in non-surgical settings (e.g. patient bedside) to free up operating room resources, a critical capability for mass casually response. This enables earlier patie... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNonSurgical Debridement - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE, a Government sector organization in USA, has announced a new tender for NonSurgical Debridement. This tender is published on USARFP under UST Ref No: 122603112 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-26.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
